Greenland Mines Ltd.
$0.16 $0.00 (+0.00%) 1D Market openKey Metrics
The Story So Far
LAST 6 MONTHS PRIMARY SOURCES ONLY-
Jul 23
A material event was filed (Form 8-K).
8-K - Greenland Mines Ltd (0001907223) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 23
From its Jun 4 high, the share price fell 53%.
Peak close $0.33 on Jun 4; trough close $0.15 on Jul 23. The drawdown is the fact — the chapters around it are the context.
RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -53% -
Jul 21
A material event was filed (Form 8-K).
8-K - Greenland Mines Ltd (0001907223) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 20
A material event was filed (Form 8-K).
8-K - Greenland Mines Ltd (0001907223) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 16
Money rotated out of high-beta cohorts market-wide.
High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.
RECEIPT: ROTATION GAUGE, LIVE -
Jun 4
The stock moved +37.9% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Jun 4 -
Mar 23
The stock moved +31.2% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Mar 23
The story updates itself as events post · The wolf reports; you decide
Snapshot
About Greenland Mines Ltd.
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases.
Wolf Grade COMING SOON
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.